New agreement streamlines Harvard research collaborations with Facebook

Innovations in cancer vaccines, microfluidic devices, reconfigurable surfaces, soft actuators, quantification of lipoproteins, drug delivery, surfactants, inhibition of necrosis, classroom tools, and much more

Startup Magenta Therapeutics licenses technologies from Harvard, MGH, and Boston Children’s that could transform treatment

Innovations in treating cancer and infection by inhibiting the PD-1 pathway; nanoelectronic tissue scaffolds; soft robotic actuators; generating direct triplet entangled photons, and more